×
> Medical Devices > Glucose Monitoring Device Market
Medical Devices MD0105 January 2020 Share

Glucose Monitoring Device Market

The growing incidence of diabetes and rising awareness about the self-administration of diabetes is filling the development of the global glucose monitoring devices market. The presentation of therapeutic gadgets that are perfect with cell phones and shrewd devices is putting forth simple access to these gadgets to an expansive number of end-clients in the global market. The incorporation glucose monitoring devices with mobile applications has facilitated the monitoring of blood glucose levels among patients.

The Glucose Monitoring Device market is expected to grow from USD XX million in 2019 to USD 6,741.6 million by 2025 at a CAGR of 6% from 2019 to 2025.

The growing incidence of diabetes and rising awareness about the self-administration of diabetes is filling the development of the global glucose monitoring devices market. The presentation of therapeutic gadgets that are perfect with cell phones and shrewd devices is putting forth simple access to these gadgets to an expansive number of end-clients in the global market. The incorporation glucose monitoring devices with mobile applications has facilitated the monitoring of blood glucose levels among patients.

The global Glucose Monitoring Device market is segregated on the basis of Product as Diabetes monitoring devices and Insulin delivery devices. Based on Application the global Glucose Monitoring Device market is segmented in Hospitals and Personal use.

The global Glucose Monitoring Device market report provides geographic analysis covering regions, such as North America, Europe, Asia-Pacific, and Rest of the World. The Glucose Monitoring Device market for each region is further segmented for major countries including the U.S., Canada, Germany, the U.K., France, Italy, China, India, Japan, Brazil, South Africa, and others.

Competitive Rivalry

Roche, DexCom, Johnson & Johnson, AstraZeneca, Insulet, Sanofi, Merck, GSK, Nova Biomedical, Becton Dickinson, and others are among the major players in the global Glucose Monitoring Device market. The companies studied in terms of product strategy and various n several growth and expansion strategies to gain a competitive edge in the market. The major players not only follow value chain integration with business operations in multiple stages of the value chain.

The global Glucose Monitoring Device market has been segmented as below:

Glucose Monitoring Device Market, By Product

  • Diabetes monitoring devices
  • Insulin delivery devices

Glucose Monitoring Device Market, By Application

  • Hospitals
  • Personal use

Glucose Monitoring Device Market, By Region

  • North America
  • Europe
  • Asia-Pacific
  • Rest of the World

Glucose Monitoring Device Market, By Company

  • Eli Lilly
  • Lupin
  • Braun
  • Takeda Pharmaceutical
  • Bayer HealthCare
  • Abbott Diabetes Care
  • Boehringer Ingelheim
  • Novo Nordisk
  • GlySens
  • Senseonics
  • Novartis
  • Omron Healthcare
  • Philips Healthcare
  • GE Healthcare
  • Medtronic
  • ResMed

The report covers the below scope:

  • Global Glucose Monitoring Device market sizes from 2015 to 2024, along with CAGR for 2018-2024
  • Market size comparison for 2017 vs 2024, with actual data for 2017, estimates for 2018 and forecast from 2019 to 2024
  • Global Glucose Monitoring Device market trends, covering comprehensive range of consumer trends & manufacturer trends
  • Value chain analysis covering participants from raw material suppliers to the downstream buyer in the global Glucose Monitoring Device market
  • Major market opportunities and challenges in forecast timeframe to be focused
  • Competitive landscape with analysis on competition pattern, portfolio comparisons, development trends and strategic management
  • Comprehensive company profiles of the key industry players

The years considered for the study are as follows:

  • Base year - 2018
  • Estimated year - 2019
  • Projected year - 2020
  • Forecast period - 2021 to 2025

Report Scope:

The global Glucose Monitoring Device market report scope includes detailed study covering underlying factors influencing the industry trends. The report covers analysis on regional and country level market dynamics. The scope also covers competitive overview providing company market shares along with company profiles for major revenue contributing companies. The report scope includes detailed competitive outlook covering market shares and profiles key participants in the global Glucose Monitoring Device market share. Major industry players with significant revenue share include Roche, DexCom, Johnson & Johnson, AstraZeneca, Insulet, Sanofi, Merck, GSK, Nova Biomedical, Becton Dickinson, and others.

Why to Buy this Report:

  • Gain detailed insights on the Glucose Monitoring Device industry trends
  • Find complete analysis on the market status
  • Identify the Glucose Monitoring Device market opportunities and growth segments
  • Analyse competitive dynamics by evaluating business segments & product portfolios
  • Facilitate strategy planning and industry dynamics to enhance decision making

Target Audience:

The report targeted towards the existing players in the industry is as follows:

  • Market Manufacturers/Service Providers
  • Market Wholesale/Traders
  • Investment and Financial Institutions

Free and Paid Customization based on the requirement

Report Content

 

  1. Introduction

            1.1 Key Insights

            1.2 Report Overview

            1.3 Markets Covered

            1.4 Stakeholders

  1. Research Methodology

            2.1 Research Scope

            2.2 Market Research Process

            2.3 Research Data Analysis

                        2.4.1 Secondary Research

                        2.4.2 Primary Research

                        2.4.3 Models for Estimation

            2.5 Market Size Estimation

                        2.5.1 Bottom-Up Approach - Segmental Market Analysis

                        2.5.2 Top-Down Approach - Parent Market Analysis

  1. Executive Summary
  2. Market Overview

            4.1 Introduction

                        4.2.1 Drivers

  • R&D and increasing technological innovations
  • Growing prevalence of diabetes on a global level

                        4.2.2 Restraints

  • Stringent rules for glucose monitoring devices
  • Standardisation and unfavourable reimbursement policies

                        4.2.3 Opportunities

  • Improvements in the self-monitoring blood glucose (SMBG) devices

                        4.2.4 Challenges

            4.2 Porter''s Five Force Analysis

  1. Glucose Monitoring Device Market, By Product

            5.1 Introduction

            5.2 Diabetes monitoring devices

                        5.2.1 Market Overview

                        5.2.2 Market Size and Forecast

            5.3 Insulin delivery devices

                        5.3.1 Market Overview

                        5.3.2 Market Size and Forecast

  1. Glucose Monitoring Device Market, By Application

            6.1 Introduction

            6.2 Hospitals

                        6.2.1 Market Overview

                        6.2.2 Market Size and Forecast

            6.3 Personal use

                        6.3.1 Market Overview

                        6.3.2 Market Size and Forecast

  1. Glucose Monitoring Device Market, By Geography

            7.1 Introduction

            7.2 North America

                        7.2.1 North America Glucose Monitoring Device, By Product

                        7.2.2 North America Glucose Monitoring Device, By Application

            7.3 Europe

                        7.3.1 Europe Glucose Monitoring Device, By Product

                        7.3.2 Europe Glucose Monitoring Device, By Application

            7.4 Asia-Pacific

                        7.4.1 Asia-Pacific Glucose Monitoring Device, By Product

                        7.4.2 Asia-Pacific Glucose Monitoring Device, By Application

            7.5 Rest of the World

                        7.5.1 Rest of the World Glucose Monitoring Device, By Product

                        7.5.2 Rest of the World Glucose Monitoring Device, By Application

  1. Competitive Insights

            8.1 Key Insights

            8.2 Company Market Share Analysis

            8.3 Strategic Outlook

                        8.3.1 Mergers & Acquisitions

                        8.3.2 New Product Development

                        8.3.3 Portfolio/Production Capacity Expansions

                        8.3.4 Joint Ventures, Collaborations, Partnerships & Agreements

                        8.3.5 Others

  1. Company Profiles
  • Roche
  • DexCom
  • Johnson & Johnson
  • AstraZeneca
  • Insulet
  • Sanofi
  • Merck
  • GSK
  • Nova Biomedical
  • Becton Dickinson
  • Eli Lilly
  • Lupin
  • Braun
  • Takeda Pharmaceutical
  • Bayer HealthCare
  • Abbott Diabetes Care
  • Boehringer Ingelheim
  • Novo Nordisk
  • GlySens
  • Senseonics
  • Novartis
  • Omron Healthcare
  • Philips Healthcare
  • GE Healthcare
  • Medtronic
  • ResMed

The global Glucose Monitoring Device market has been segmented as below:

Glucose Monitoring Device Market, By Product

  • Diabetes monitoring devices
  • Insulin delivery devices

Glucose Monitoring Device Market, By Application

  • Hospitals
  • Personal use

Glucose Monitoring Device Market, By Region

  • North America
  • Europe
  • Asia-Pacific
  • Rest of the World

Glucose Monitoring Device Market, By Company

  • Eli Lilly
  • Lupin
  • Braun
  • Takeda Pharmaceutical
  • Bayer HealthCare
  • Abbott Diabetes Care
  • Boehringer Ingelheim
  • Novo Nordisk
  • GlySens
  • Senseonics
  • Novartis
  • Omron Healthcare
  • Philips Healthcare
  • GE Healthcare
  • Medtronic
  • ResMed

FAQ's

  • Global
  • 180Pages
  • ProMarket Research
License Options


 

Subscribe our Newsletter

Please Subscribe for exciting offers and for new reports.